Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil

Authors

DOI:

https://doi.org/10.11606/s1518-8787.2022056004154

Keywords:

Patients, Tuberculosis, Multidrug-Resistant, diagnosis, Barriers to Access of Health Services, Health Knowledge, Attitudes, Practice, Qualitative Research

Abstract

OBJECTIVE To understand patients’ narratives about the barriers they faced in the diagnosis and treatment of multidrug-resistant tuberculosis, and their consequences in Rio de Janeiro State, Brazil. METHODS This is a qualitative cross-sectional study with non-probabilistic sampling. A theoretical saturation criterion was considered for composing the number of interviewees. Semi-structured interviews were conducted from August to December 2019 with 31 patients undergoing treatment for multidrug-resistant tuberculosis at an outpatient referral center in Rio de Janeiro. Data were transcribed and processed with the aid of the NVIVO software. Interviews were evaluated by content analysis, and their themes, cross-referenced with participants’ characterization data. RESULTS Our main findings were: a) participants show a high proportion of primary drug resistance, b) patients experience delays in the diagnosis and effective treatment of multidrug-resistant tuberculosis ; c) healthcare providers fail to value or seek the diagnosis of drug-resistant tuberculosis, thus beginning the inadequate treatment for drug-susceptible tuberculosis, d) primary health units show low report rates of active case-finding and contact monitoring, and e) patients show poor knowledge about the disease. CONCLUSIONS We need to improve referral systems, and access to the diagnosis and effective treatment of multidrug-resistant tuberculosis; conduct an active investigation of contacts; intensify the training of healthcare providers, in collaboration with medical and nursing schools, in both public and private systems; and promote campaigns to educate the population on tuberculosis signs and symptoms.

References

World Health Organization. Global Tuberculosis Report 2020. Geneva (CH): WHO; 2020 [cited 2020 Nov 13]. Available from: https://www.who.int/publications/i/item/9789240013131

Ministério da Saúde (BR), Secretaria de Vigilância em Saúde, Departamento de Doenças Condições Crônicas e Infecções Sexualmente Transmissíveis. Tuberculose 2020. Bol Epidemiol. 2020 [cited 2021 Mar 15];Nº Espec:1-39. http://www.aids.gov.br/pt-br/pub/2020/boletim-epidemiologico-de-turbeculose-2020

Instituto Brasileiro de Geografia e Estatítica. Censo demográfico 2010: Características gerais da população, religião e pessoas com deficiência. Rio de Janeiro: IBGE; 2012 [cited 2021 Mar 10]. Available from: https://biblioteca.ibge.gov.br/visualizacao/periodicos/94/cd_2010_religiao_deficiencia.pdf

Rudgard WE, Chagas NS, Gayoso R, Barreto ML, Boccia D, Smeeth L, et al. Uptake of governmental social protection and financial hardship during drug-resistant tuberculosis treatment in Rio de Janeiro, Brazil. Eur Respir J. 2018;51(3):1800274. https://doi.org/10.1183/13993003.00274-2018

Ministério da Saúde (BR), Secretaria de Vigilância em Saúde, Departamento de Vigilância Epidemiológica. Manual de recomendações para o controle da tuberculose no Brasil. 2. ed atual. Brasília, DF; 2019 [cited 2021 Feb15]. Available from: https://bvsms.saude.gov.br/bvs/publicacoes/manual_recomendacoes_controle_tuberculose_brasil_2_ed.pdf

Nathavitharana RR, Lederer P, Tierney DB, Nardell E. Treatment as prevention and other interventions to reduce transmission of multidrug-resistant tuberculosis. Int J Tuberc Lung Dis. 2019;23(4):396-404. https://doi.org/10.5588/ijtld.18.0276

WHO consolidated guidelines on drug-resistant tuberculosis treatment. Geneva (CH): World Health Organization; 2019.

Shringarpure KS, Isaakidis P, Sagili KD, Baxi RK, Das M, Daftary A. "When treatment is more challenging than the disease": a qualitative study of MDR-TB Patient Retention. PLoS One. 2016;11(3):e0150849. https://doi.org/10.1371/journal.pone.0150849

Tong A, Sainsbury P, Craig J. Consolidated criteria for reporting qualitative research (COREQ): a 32-item checklist for interviews and focus groups. Int J Qual Health Care. 2007;19(6):349-57. https://doi.org/10.1093/intqhc/mzm042

Shenton, AK. Strategies for ensuring trustworthiness in qualitative research projects. Educ Information. 2004;22(2):63-75. https://doi.org/10.3233/EFI-2004-22201

Minayo MCS, Deslandes SF, Gomes R. Pesquisa Social: teoria, método e criatividade. Petrópolis, RJ: Vozes; 2011. (Temas Sociais).

Minayo MCS. Análise qualitativa: teoria, passos e fidedignidade. Cienc Saude Coletiva. 2012;17(3):621-6. https://doi.org/10.1590/S1413-81232012000300007

Fontanella BJB, Luchesi BM, Saidel MGB, Ricas J, Turato ER, Melo DG. [Sampling in qualitative research: a proposal for procedures to detect theoretical saturation]. Cad Saude Publica. 2011;27(2):389-94. Portuguese. https://doi.org/10.1590/s0102-311x2011000200020

Narasimhan P, Wood J, MacIntyre CR, Mathai D. Risk factors for tuberculosis. Pulmonary Med. 2013;2013:828939. https://doi.org/10.1155/2013/828939

Bardin L. Análise de conteúdo. Lisboa (PT): Edições 70; 2011

Riessman CK. Narrative analysis. London (Uk): Sage; 1993. (Qualitative Research Methods; Vol. 30).

Trading Ecomonics. Brazil - Official Exchange Rate, LCU Per USD, Period Average [cited 2020 Dec 15]. Available from: https://tradingeconomics.com/brazil/official-exchange-rate-lcu-per-usd-period-average-wb-data.html

Machado ACFT, Steffen RE, Oxlade O, Menzies D, Kritski A, Trajman A. Fatores associados ao atraso no diagnóstico da tuberculose pulmonar no Estado do Rio de Janeiro. J Bras Pneumol 2011;37(4):512-20. https://doi.org/10.1590/S1806-37132011000400014

Lienhardt C, Rowley J, Manneh K, Lahai G, Needham D, Milligan P, et al. Factors affecting time delay to treatment in a tuberculosis control programme in a sub-Saharan African country: the experience of The Gambia. Int J Tuberc Lung Dis. 2001;5(3):233-9.

Storla DG, Yimer S, Bjune GA. A systematic review of delay in the diagnosis and treatment of tuberculosis. BMC Public Health. 2008;8:15. https://doi.org/10.1186/1471-2458-8-15

Sá LD; Barrêto AJR, Nogueira JA, Cunha FTS, Palha PF, Villa TCS. The discourse of health managers on aspects related to the delay in tuberculosis diagnosis Rev Esc Enferm USP. 2013;47(5):1170-7. https://doi.org/10.1590/S0080-623420130000500022

Almeida CPB, Skupien EC, Silva DR. Health care seeking behavior and patient delay in tuberculosis diagnosis. Cad Saude Publica. 2015;31(2):321-30. https://doi.org/10.1590/0102-311X00195413

Anderson LF, Tamne S, Brown T, Watson JP, Mullarkey C, Zenner D, et al. Transmission of multidrug-resistant tuberculosis in the UK: a cross-sectional molecular and epidemiological study of clustering and contact tracing. Lancet Infect Dis. 2014;14(5):406-15. https://doi.org/10.1016/S1473-3099(14)70022-2

Yang C, Luo T, Shen X, Wu J, Gan M, Xu P, et al. Transmission of multidrug-resistant Mycobacterium tuberculosis in Shanghai, China: a retrospective observational study using whole-genome sequencing and epidemiological investigation. Lancet Infect Dis. 2017;17(3):275-84. https://doi.org/10.1016/S1473-3099(16)30418-2

Dobler CC, Korver S, Batbayar O, Nyamdulam B, Oyuntsetseg S, Tsolmon B, et al. Multidrug-resistant tuberculosis in patients for whom first-line treatment failed, Mongolia, 2010-2011. Emerg Infect Dis. 2015;21(8):1451-4. https://doi.org/10.3201/eid2108.141860

Bhering M, Duarte R, Kritski A. Predictive factors for unfavourable treatment in MDR-TB and XDR-TB patients in Rio de Janeiro State, Brazil, 2000-2016. PLoS One. 2019;14(11):e0218299. https://doi.org/10.1371/journal.pone.0218299

Ballestero JGA, Garcia JM, Bollela VR, Ruffino Netto A, Dalcomo MMP, Moncaio ACS, et al. Manejo da tuberculose multirresistente: elementos centrais das recomendações brasileiras. J Bras Pneumol. 2020;46(2):1-9. https://doi.org/10.36416/1806-3756/e20190290

Albert H, Nathavitharana RR, Isaacs C, Pai M, Denkinger CM, Boehme CC. Development, roll-out and impact of Xpert MTB/RIF for tuberculosis: what lessons have we learnt and how can we do better? Eur Respir J. 2016;48(2):516-25. https://doi.org/10.1183/13993003.00543-2016

World Health Organization (WHO). Latent tuberculosis infection: updated and consolidated guidelines for programmatic management. Geneva (CH): WHO; 2018 [cited 2021 Feb 13]. Available from: https://www.who.int/tb/publications/2018/latent-tuberculosis-infection/en/

Fox GJ, Anh NT, Nhung NV, Loi NT, Hoa NB, Ngoc Anh LT, et al. Latent tuberculous infection in household contacts of multidrug-resistant and newly diagnosed tuberculosis. Int J Tuberc Lung Dis. 2017;21(3):297-302. https://doi.org/10.5588/ijtld.16.0576

Gupta A, Swindells S, Kim S, Hughes MD, Naini L, Wu X, et al. Feasibility of identifying household contacts of rifampin-and multidrug-resistant tuberculosis cases at high risk of progression to tuberculosis disease. Clin Infect Dis. 2020;70(3):425-35. https://doi.org/10.1093/cid/ciz235

Kigozi NG, Heunis JC, Engelbrecht MC, Rensburg APJ, Rensburg HCJD. Tuberculosis knowledge, attitudes and practices of patients at primary health care facilities in a South African metropolitan: research towards improved health education. BMC Public Health. 2017;17(1):795. https://doi.org/10.1186/s12889-017-4825-3

Asres M, Gedefaw M, Kahsay A, Weldu Y. Patients' delay in seeking health care for tuberculosis diagnosis in East Gojjam Zone, Northwest Ethiopia. Am J Trop Med Hyg. 2017;96(5):1071-5. https://doi.org/10.4269/ajtmh.16-0892

Li Y, Ehiri J, Tang S, Li D, Bian Y, Marshall C, et al. Factors associated with patient, and diagnostic delays in Chinese TB patients: a systematic review and meta-analysis. BMC Med. 2013;11:156. https://doi.org/10.1186/1741-7015-11-156

Lacerda SNB, Temoteo RCA, Figueiredo TMRM, Luna FDT, Sousa MAN, Abreu LV, et al. Individual and social vulnerabilities upon acquiring tuberculosis: a literature systematic review. Int Arch Med. 2014;7:35. https://doi.org/10.1186/1755-7682-7-35

Sá LD, Gomes ALC, Carmo JB, Souza KMJ, Palha PF, Alves RS, et al. Educação em saúde no controle da tuberculose: perspectiva de profissionais da estratégia Saúde da Família. Rev Eletron Enferm. 2013;15(1):103-11. https://doi.org/10.5216/ree.v15i1.15246

Downloads

Published

2022-06-24

Issue

Section

Original Articles

How to Cite

Bhering, M. ., Dalcolmo, M., Sarubbi Júnior, V., & Kritski, A. . (2022). Barriers faced by patients in the diagnosis of multidrug-resistant tuberculosis in Brazil. Revista De Saúde Pública, 56, 60. https://doi.org/10.11606/s1518-8787.2022056004154